Thyroid disease

Efficacy and Safety of Adjunctive Bile Acid Sequestrant Therapy for Thyrotoxicosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

ThyroidPublished Systematic review and meta-analysis of randomised controlled trials

Authors' conclusion

Adjunctive bile acid sequestrants with standard hyperthyroidism therapy appear to enhance reductions in serum total T3 and free T4 at the mark of four weeks and were well tolerated. However, due to considerable heterogeneity and low quality of evidence, our results should be interpreted with caution. Larger, high-quality RCTs are needed to strengthen the evidence regarding the efficacy of adjunctive bile acid sequestrant therapy.

Study context

Population
Adult non-critically ill patients with hyperthyroidism (Graves' disease, toxic adenoma, multinodular goiter)
Participants
173 patients5 randomized controlled trials (RCTs)
Comparison
Standard therapy plus adjunctive bile acid sequestrants vs standard therapy alone
  • Adjunctive bile acid sequestrantsn = 93
  • Standard therapyn = 80reference
Outcome
Reduction in serum FT4 and total T3

Pooled result

As reported in the abstract

4 weeks

Total T3, adjunctive bile acid sequestrants vs standard therapy alone: MD (95% CI) — statistically significant reduction

−1.59 nmol/L

−2.90 to −0.27

Free T4, adjunctive bile acid sequestrants vs standard therapy alone: MD (CI) — statistically significant reduction

−1 ng/dL

−1.74 to −0.25

Further pooled results

OutcomeMD (nmol/L) (95% CI)
Reduction in serum total T3 and free T4 · 2 weeksBile acid sequestrantsvs Standard therapyTotal T3; non-significant reduction−0.44 (−1.2 to +0.32)
OutcomeMD (ng/dL) (95% CI)
Reduction in serum total T3 and free T4 · 2 weeksBile acid sequestrantsvs Standard therapyFree T4; non-significant reduction−0.55 (−1.15 to +0.04)

Safety

Tolerability

Adjunctive bile acid sequestrants were well tolerated

Original publication

Efficacy and Safety of Adjunctive Bile Acid Sequestrant Therapy for Thyrotoxicosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Thyroid. Published 18 December 2025. doi:10.1177/10507256251409074

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.